{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:50:22Z","timestamp":1775487022955,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1093\/toxsci\/kfs270","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T05:22:26Z","timestamp":1347081746000},"page":"302-310","source":"Crossref","is-referenced-by-count":30,"title":["Involvement of Interleukin-6-Regulated Nitric Oxide Synthase in Hemorrhagic Cystitis and Impaired Bladder Contractions in Young Rats Induced by Acrolein, a Urinary Metabolite of Cyclophosphamide"],"prefix":"10.1093","volume":"131","author":[{"given":"Ching-Chia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te-I","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shing-Hwa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"key":"key\n\t\t\t\t20170315214258_CIT0001","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.urology.2008.10.039","article-title":"Aminoguanidine, selective nitric oxide synthase inhibitor, ameliorates cyclophosphamide-induced hemorrhagic cystitis by inhibiting protein nitration and PARS activation","volume":"73","year":"(2009)","journal-title":"Urology"},{"key":"key\n\t\t\t\t20170315214258_CIT0002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.bmt.1701355","article-title":"Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients","volume":"22","year":"(1998)","journal-title":"Bone Marrow Transplant."},{"key":"key\n\t\t\t\t20170315214258_CIT0003","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)65348-7","article-title":"Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer","volume":"167","year":"(2002)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0004","first-page":"1475","article-title":"A model of hemorrhagic cystitis induced with acrolein in mice","volume":"39","year":"(2006)","journal-title":"Braz. J. Med. Biol. Res."},{"key":"key\n\t\t\t\t20170315214258_CIT0005","first-page":"71","article-title":"Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis","volume":"59","year":"(2007)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170315214258_CIT0500","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.urology.2005.07.049","article-title":"Human detrusor smooth muscle cells release interleukin-6, interleukin- 8, and RANTES in response to proinflammatory cytokines interleukin- 1beta and tumor necrosis factor-\u03b1","volume":"67","year":"2006","journal-title":"Urology"},{"key":"key\n\t\t\t\t20170315214258_CIT0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0305-7372(83)80005-X","article-title":"The development of mesna for regional detoxification","volume":"10","year":"(1983)","journal-title":"Cancer Treat. Rev."},{"key":"key\n\t\t\t\t20170315214258_CIT0007","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0277-5379(81)80019-3","article-title":"Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds","volume":"17","year":"(1981)","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"key\n\t\t\t\t20170315214258_CIT0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000073369","article-title":"Ifosfamide in pediatric solid tumors","volume":"65","year":"(2003)","journal-title":"Oncology"},{"key":"key\n\t\t\t\t20170315214258_CIT0009","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"44","year":"(2005)","journal-title":"Clin. Pharmacokinet."},{"key":"key\n\t\t\t\t20170315214258_CIT0010","first-page":"428","article-title":"Ifosfamide\/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer","volume":"42","year":"(1991)","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170315214258_CIT0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/j.1552-4604.1997.tb04344.x","article-title":"Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation","volume":"37","year":"(1997)","journal-title":"J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20170315214258_CIT0012","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0300-483X(92)90007-2","article-title":"Murine strain differences in metabolism and bladder toxicity of cyclophosphamide","volume":"75","year":"(1992)","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170315214258_CIT0013","first-page":"1103","article-title":"Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis","volume":"28","year":"(1995)","journal-title":"Braz. J. Med. Biol. Res."},{"key":"key\n\t\t\t\t20170315214258_CIT0014","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-5347(17)44929-9","article-title":"Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy","volume":"136","year":"(1986)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1399-3046.2011.01505.x","article-title":"Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children","volume":"15","year":"(2011)","journal-title":"Pediatr. Transplant."},{"key":"key\n\t\t\t\t20170315214258_CIT0016","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2125.1993.tb04152.x","article-title":"Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation","volume":"35","year":"(1993)","journal-title":"Br. J. Clin. Pharmacol."},{"key":"key\n\t\t\t\t20170315214258_CIT0017","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.juro.2009.01.015","article-title":"Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation","volume":"181","year":"(2009)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0018","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","year":"(2007)","journal-title":"Cell Biol. Toxicol."},{"key":"key\n\t\t\t\t20170315214258_CIT0019","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5347(17)41173-6","article-title":"Urological complications of cyclophosphamide","volume":"141","year":"(1989)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0020","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0022-5347(05)67103-0","article-title":"Protein kinase c regulates purinergic component of neurogenic contractions in mouse bladder","volume":"164","year":"(2000)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0021","first-page":"19","article-title":"Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats","volume":"134","year":"(2008)","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"key\n\t\t\t\t20170315214258_CIT0022","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0090-4295(03)00131-6","article-title":"Nitric oxide and the lower urinary tract: Current concepts, future prospects","volume":"61","year":"(2003)","journal-title":"Urology"},{"key":"key\n\t\t\t\t20170315214258_CIT0023","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00120-007-1479-2","article-title":"[Lipopolysaccharide-mediated regulation of interleukin-6 in cultured human detrusor smooth muscle cells]","volume":"46","year":"(2007)","journal-title":"Urologe. A"},{"key":"key\n\t\t\t\t20170315214258_CIT0024","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1442-2042.2006.01536.x","article-title":"Up-regulation of interleukin-6 gene expression in cyclophosphamide-induced cystitis in mice: An in situ hybridization histochemical study","volume":"13","year":"(2006)","journal-title":"Int. J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0025","first-page":"185","article-title":"Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats","volume":"32","year":"(2004)","journal-title":"Urol. Res."},{"key":"key\n\t\t\t\t20170315214258_CIT0026","first-page":"1577","article-title":"Cyclophosphamide and urinary bladder toxicity","volume":"21","year":"(1961)","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170315214258_CIT0027","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0022-5347(05)65134-8","article-title":"Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice","volume":"167","year":"(2002)","journal-title":"J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0028","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199310000-00020","article-title":"Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications","volume":"56","year":"(1993)","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20170315214258_CIT0029","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines","volume":"15","year":"(1997)","journal-title":"Annu. Rev. Immunol."},{"key":"key\n\t\t\t\t20170315214258_CIT0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00686313","article-title":"Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients","volume":"30","year":"(1992)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170315214258_CIT0031","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","year":"(2002)","journal-title":"Pharmacol. Rev."},{"key":"key\n\t\t\t\t20170315214258_CIT0032","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00148581-200709060-00006","article-title":"Optimal management strategies for rhabdomyosarcoma in children","volume":"9","year":"(2007)","journal-title":"Paediatr. Drugs"},{"key":"key\n\t\t\t\t20170315214258_CIT0033","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1464-410X.1973.tb12230.x","article-title":"Urological complications of cyclophosphamide","volume":"45","year":"(1973)","journal-title":"Br. J. Urol."},{"key":"key\n\t\t\t\t20170315214258_CIT0034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2005.02.005","article-title":"Bladder instillation of Escherichia coli lipopolysaccharide alters the muscle contractions in rat urinary bladder via a protein kinase C-related pathway","volume":"208","year":"(2005)","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20170315214258_CIT0035","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/509620","article-title":"Uropathogenic Escherichia coli alters muscle contractions in rat urinary bladder via a nitric oxide synthase-related signaling pathway","volume":"194","year":"(2006)","journal-title":"J. Infect. Dis."},{"key":"key\n\t\t\t\t20170315214258_CIT0036","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/IAI.00013-09","article-title":"Uropathogenic Escherichia coli-induced inflammation alters mouse urinary bladder contraction via an interleukin-6-activated inducible nitric oxide synthase-related pathway","volume":"77","year":"(2009)","journal-title":"Infect. Immun."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/131\/1\/302\/11003405\/kfs270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T16:11:06Z","timestamp":1562170266000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/1625673\/Involvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,9,7]]},"published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfs270","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]}}}